Human CXCL13/BCA-1 ELISA Kit

Key features and details

  • Specification: 96 Test
  • Sensitivity: 0.56 pg/ml (50 μl);5.32 pg/ml (10 μl);
  • Standard Curve Range: 7.81~500 pg/ml
  • Standard Curve Gradient: 7 Points
  • Number of Incubations: 2
  • Sample Volume: 50 μl/10 μl
  • Assay type: Sandwich Elisa
  • Operation Duration: 120min
  • Brand:
CAT.NO. : AEH0172
RMB Please choose
RMB Please choose
Size:
96T
Trail, Bulk size or Custom requests Please contact us
Product Details
Background
CXCL13/BLC/BCA-1 is a constitutively expressed chemokine that plays an important role in B and T cell homing. It is expressed by salivary gland epithelium, dendritic cells, osteoclasts, and peritoneal macrophages. It can form homodimers or heterodimers with FGF basic, and it signals through CXCR3 or CXCR5. CXCL13 induces the migration of naïve B cells and a subset of memory T cells to lymphoid tissue. It also promotes B1 cell migration into the omentum and peritoneum. In the fetus, CXCL13 attracts CD4+ CD3- IL-7 R alpha+ hematopoietic cells to sites of future Peyer’s patch development.
Typical data

pg/ml

O.D.

Average

Corrected

0.00

0.0076

0.0074

0.0075

7.81

0.0260

0.0265

0.0263

0.0188

15.63

0.0515

0.0509

0.0512

0.0437

31.25

0.1190

0.1180

0.1185

0.1110

62.50

0.2836

0.2700

0.2768

0.2693

125.00

0.7076

0.6990

0.7033

0.6958

250.00

1.8240

1.8140

1.8190

1.8115

500.00

3.5660

3.6350

3.6005

3.5930

Precision

Intra-assay Precision

Inter-assay Precision

Sample Number

S1

S2

S3

S1

S2

S3

22

22

22

6

6

6

Average(pg/ml)

19.3

78.3

213.9

18.5

76.1

216.7

Standard Deviation

0.7

2.7

9.6

0.7

2.3

7.1

Coefficient of Variation(%)

3.4

3.4

4.5

3.8

3.0

3.3

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human CXCL13/BCA-1 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 80% to 120% with an overall mean recovery of 96%.
Sample Values
Sample Matrix Sample Evaluated Range (pg/ml) Detectable (%) Mean of Detectable (pg/ml)
Serum 30 28.44-275.19 100 71.8
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of CXCL13/BCA-1 in this assay. No medical histories were available for the donors.
New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap